Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
Van Delden
C
C
Hirschel
B
B
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000188:drug therapy*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D011739:Pyrimethamine / Q000627:therapeutic use*; D012189:Retrospective Studies; D013411:Sulfadiazine / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy*; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D004338:Drug Combinations; D013411:Sulfadiazine; D002955:Leucovorin; D011739:Pyrimethamine